Myelodysplastic syndromes as preleukemic states
Sánchez Fayos, J.; Pérez Rus, G.; Outeiriño, J.; Escudero, A.; Bosch, J.M.; Calabuig, T.; Vacas, J.
Sangre 32(6): 715-730
1987
ISSN/ISBN: 0036-4355 PMID: 3326193 Document Number: 299446
Document emailed within 1 workday
Related Documents
Tassin, F.; Hermanne, J.P.; Schaaf-Lafontaine, N.; Herens, C.; Thiry, A.; Paulus, J.M.; Boniver, J.; Fillet, G. 1998: Myelodysplastic syndromes: preleukemic syndromes Revue Medicale de Liege 53(6): 357-362Nasu, H.; Hibi, N.; Ohyashiki, J.H.; Hara, A.; Kubono, K.; Tsukada, Y.; Ando, K.; Iwama, H.; Hayashi, S.; Yahata, N.; Toyama, K.; Ohyashiki, K. 1998: Serum soluble CD44 levels for monitoring disease states in acute leukemia and myelodysplastic syndromes International Journal of Oncology 13(3): 525-530
Barbieri, D.; Chelazzi, G. 1972: Myeloaplastic preleukemic syndromes. a propos of 3 cases Haematologica 58(9): 567-570
Vacarezza, R. 1982: Preleukemic states Revista Medica de Chile 110(7): 679-686
Micou, D. 1979: Preleukemic states Medecine Interne 17(4): 313-321
Sabashvili, M.K.; Meunargiia, V.V. 1984: Immunologic disorders in preleukemic states Gematologiia i Transfuziologiia 29(10): 21-23
Lishner, M.; Ravid, M. 1988: Myelodysplastic syndromes Harefuah 115(3-4): 73-76
Dusek, J.; Bednár, B.; Dorazilová, V.; Fakan, F.; Kerekes, Z. 1990: Myelodysplastic syndromes Ceskoslovenska Patologie 26(3): 129-134
Guisasola Zulueta, M.C.; Gilsanz Fernández, C.; Tintó del Val, J.A.; García de la Fuente, A. 1986: Myelodysplastic syndromes Revista Clinica Espanola 179(4): 190-195
Sizoo, W.; Hagenbeek, A.; Löwenberg, B.; van 't Veer, M.B.; Sintnicolaas, K. 1987: Myelodysplastic syndromes Nederlands Tijdschrift Voor Geneeskunde 131(38): 1658-1661
Strebel, U. 1988: Myelodysplastic syndromes Therapeutische Umschau. Revue Therapeutique 45(2): 100-105
Turtureanu-Hanganu, E. 2004: The point on myelodysplastic syndromes Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 108(1): 9-16
Solary, E.; Fontenay, M.ël. 2010: Myeloproliferative/myelodysplastic syndromes La Revue du Praticien 60(10): 1413-1415
Carvajal Méndez, I.; García Vadillo, J.A.; Herranz Varela, A.; González Alvaro, I.; Casado Montero, F.; Castañeda Sanz, S. 1996: Polyarthritis associated with myelodysplastic syndromes Revista Clinica Espanola 196(8): 539-541
Doll, D.C.; List, A.F. 1992: Myelodysplastic syndromes: introduction Seminars in Oncology 19(1): 1-3
Tohyama, K. 2012: Treatment of myelodysplastic syndromes (MDS) Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 2): 367-372
Dreyfus, F.; Bouscary, D.; Melle, J.; Ribrag, V.; Guesnu, M.; Varet, B. 1995: Expression of the Evi-1 gene in myelodysplastic syndromes Leukemia 9(1): 203-205
Peskin, S.R. 2009: Myelodysplastic syndromes (MDS): the current landscape Managed Care 18(11 Suppl 9: 2-3
Jonveaux, P.; Fenaux, P.; Quiquandon, I.; Pignon, J.M.; Laï, J.L.; Loucheux-Lefebvre, M.H.; Goossens, M.; Bauters, F.; Berger, R. 1991: Mutations in the p53 gene in myelodysplastic syndromes Oncogene 6(12): 2243-2247
Kim, H.; Garcia-Manero, G. 2008: Management of myelodysplastic syndromes: just the beginning Oncology 22(12): 1360; 1363, 1368